2.000
+0,00%
2026-10-16
Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +149.3% | +1101.3% | 3 / 3 | +48.6% | +27.05 pp | +7.69 pp | -3.7% | -1.10 | 11.69 | 49,3 | +48,6% | 0,8 | +137,2% | 11.69 | 26.54 | −56,0% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 2.000 (close price on 2026-10-16)EPS (TTM): 171,1
Financial charts
1.Revenue & growth
VND bn49,3Q2/26
1.Revenue & growth
VND bn49,3Q2/26
2.Profit & growth
VND bn0,75Q2/26
3.Profit mix (Penman)
VND bn10,1Q2/26
4.Margins & cost structure
%31.0%Q2/26
5.Returns & cash cycle
% · days137%Q2/26
6.Earnings quality & cash
VND bn-1,92Q2/26
7.Asset structure
VND bn824Q2/26
8.Funding & debt health
VND bn · times824Q2/26
9.Revenue backlog
VND bn10,6Q2/26
10.Valuation
times · %11,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %30Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26